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Abstract
Background: For peritoneal dialysis patients, the likelihood of conception is low and the probability of getting
through the pregnancy successfully is even lower. Almost 60 years after the first reported case of a successful
pregnancy in a dialysis patient, many issues concerning pregnancy in dialysis patients remain unresolved. Our
patient’s pregnancy is considered high risk as she has end stage renal failure and falls in the category of advance
maternal age for pregnancy. We describe here the course of her uneventful pregnancy which we hope will
contribute to the overall knowledge and management of pregnancy in elderly patients receiving peritoneal dialysis.
Case presentation: We report a successful elderly multigravid pregnancy, in a patient undergoing continuous
ambulatory peritoneal dialysis (CAPD). Her pregnancy was detected early and she was closely managed by the
nephrologist and obstetrician. She tolerated the same PD prescription throughout 36 weeks of pregnancy with daily
ultrafiltration of 500-1500mls. Her blood pressure remained well controlled without the need of any antihypertensive
medication. Her total Kt/V ranged from 1.93 to 2.73. Her blood parameters remained stable and she was electively
admitted at 36 weeks for a trans-peritoneal lower segment caesarian section and bilateral tubal ligation.
Conclusions: At the age of 42, our case is the oldest reported successful pregnancy in a patient on peritoneal dialysis.
With careful counselling and meticulous follow up, we have shown that woman in the early stage of end stage renal
failure can successfully deliver a full term baby without any complications. Therefore, these women should not be
discourage from conceiving even if they are in advanced maternal age for pregnancy.
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Background
Women who conceive while on renal replacement
therapy (RRT) are at high risk of encountering life
threatening maternal and fetal complications. Elderly
pregnancy is associated with an increase in obstetric
complications such as antepartum haemorrhage, malpre-
sentation, fetal death, low birth weight, preterm delivery
and placenta previa. On the other hand, pregnancy while
on RRT increases the risk of neonatal death, premature
delivery, miscarriage, maternal hypertension and pre-
eclampsia. These complications are much feared by
obstetricians and nephrologists. Peritoneal dialysis (PD)
has a significant advantage over haemodialysis as far as a
successful pregnancy is concerned. Intensive and custo-
mised PD prescription as well as preservation of urine
output is the mainstay of management. Maintenance of
optimal blood pressure and regular antenatal follow up
is of utmost importance.
Case presentation
We present a case of a 42 year-old mother of 4 with end
stage renal disease (ESRD) secondary to IgA Nephropathy.
She has been on CAPD since April 2015. Her past
obstetric history includes 2 prior spontaneous vaginal
deliveries and 2 lower segment caesarean sections. Her
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first pregnancy was in 1997 and her second pregnancy
was in 1998. Both antenatal follow ups were uneventful.
She underwent uncomplicated spontaneous vaginal
deliveries in pregnancies. Her third pregnancy in 2003 was
via emergency caesarean section following the obstetric
indication of impending birth asphyxia. In the first trimes-
ter of her fourth pregnancy in 2008, she was diagnosed
with asymptomatic proteinuria and haematuria. Her renal
function was noted to be normal. Towards her last trimes-
ter, an antihypertensive drug was initiated for maintenance
of optimal blood pressure. She delivered a healthy baby
via caesarean section at 36 weeks as her blood pressure
remained unfavourable. Unfortunately, she never attended
outpatient follow up appointments with us for 5 years
following her delivery. In 2013, she reappeared with
uncontrolled blood pressure and advance renal impair-
ment. She was referred to the nephrologist and a renal
biopsy was performed, confirming the diagnosis of IgA
nephropathy. She required initiation of renal replacement
therapy in 2015.
She was doing well on CAPD, with four 2 L exchanges
per day, using 1.5% bags for each exchange. Her residual
urine output was good, around 1000 ml per day during
the first trimester and decreased to 600 ml during the
last trimester. Five months following the initiation of
CAPD, she presented to our PD unit with amenorrhoea.
She was subsequently confirmed to be in the 7th week
of pregnancy. After providing extensive counselling to
the patient and her spouse regarding the potential com-
plications associated with ESRD and advance maternal
age, they decided to continue with the pregnancy. She
attended monthly antenatal clinic reviews during her
first trimester followed by fortnightly reviews from the
second trimester onwards. Regular fetal surveillance was
carried out. Her medication list was scrutinised to en-
sure that there were no contraindications in pregnancy.
Apart from the initiation of 75 mg asprin once per day,
her usual medications which were ferrous fumarate
200 mg per day, folic acid 5 mg per day, vitamin b com-
plex one tab once per day, calcium carbonate 1 g three
times a day and bumetanide 1 mg twice a day was main-
tained. She tolerated the same PD prescription through-
out 36 weeks of pregnancy with daily ultrafiltration of
500-1500mls. Her blood pressure remained well con-
trolled between 118–134/75–94 mmHg without antihy-
pertensive medication. Her erythropoietin dosage was
increased from the baseline dosage of 4000 iu weekly to
8000 iu weekly during her second trimester, with which
she was able to maintain stable haemoglobin readings of
between 8.8 and 11.5 g/dL. Her total Kt/V was 2.73 (di-
alysate 1.41, residual 1.32) during the first trimester and
this decreased to 1.93 (dialysate 1.28, residual 0.64) dur-
ing her third trimester. Serum albumin levels remained
within the range of 30–36 g/L. As her obstetric course
remained uneventful, she was electively admitted at
36 weeks for a trans-peritoneal lower segment caesarian
section (LCSC) and bilateral tubal ligation. The PD
catheter was not removed but capped up for future used.
She delivered a healthy baby girl weighing 2.5 kg with an
Apgar score of 7–8. Both mother and baby were well
and discharged the day after delivery. We inserted an
internal jugular catheter for her and she now undergoes
interim haemodialysis (HD) while awaiting the complete
healing of her LSCS scar, before resuming PD.
Discussion
The first successful pregnancy in a dialysis patient was
reported 55 years ago by Confortini [1]. However the
first sustained pregnancy in peritoneal dialysis was
reported 12 years later in a woman who conceived after
2.5 years on continuous peritoneal dialysis. The preg-
nancy was sustained until 30 weeks following which the
patient went through spontaneous labour and delivered
of a stillborn infant [2]. Over time, the successful preg-
nancy rate has improved from 23% reported by the
European Dialysis and Transplant association [3] to over
70% reported by a few case series [4, 5]. An evidence
based analysis covering pregnant ESRD women on
haemodialysis from 2000 to 2008 showed the overall
possibility of a pregnancy resulting in living offspring,
ranged from 50 to 100%. However report biases are to
be expected as any positive data will invariably be sub-
mitted for publication by the successful centres [6].
Pregnancy in ESRD women is relatively difficult, as
fertility is markedly reduced due to anovulation and
amenorrhea. Despite having normal estradiol levels dur-
ing the follicular phase of the menstrual cycle, the surge
of both leutinizing and follicle stimulating hormone does
not occur and this is worsened by low progesterone
levels in ESRD women on dialysis. Furthermore, hyper-
prolactineamia is common and seen in over 70% of
women on dialysis. Coupled with reduced libido, it is
not surprising that the conception rate has been low and
reported to be in the region of 0.3–4.1% [7, 8].
In our patient, due to irregularity of menstruation, the
diagnosis of pregnancy was at 7th week. This is much
earlier as compare to the mean time of diagnosis of
16.5th week [1]. Despite the presence of residual urine
output, the usual urine pregnancy test is not helpful in
ESRD patients. Serum levels of the beta subunit of
Human chorionic gonadotropin (HCG) are found to be
mild to moderately elevated in dialysis patients who are
not pregnant. This hormone is produced in small
amounts by other cells and it is dependent on the kidney
for a substantial part of its excretion. Since a once off
serum beta HCG level is not reliable in dialysis patients,
pregnancy is normally confirmed by the ultrasound im-
aging. Fetal cardiac activity can be first detected at 5.5–
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6 weeks and can be missed if imaging is done earlier
due to wrong gestational age dating. If a non-viable
pregnancy is suspected in a dialysis patient, the
diagnosis should be confirmed by measuring the serial
beta HCG as it decreases in a non-viable pregnancy.
This will prevent termination of a viable pregnancy in
situations where the gestational age has been inaccur-
ately calculated. Early detection of pregnancy is
crucial for the nephrologist and obstetrician. Medica-
tions that are potentially harmful to the fetus, require
substitution or dose modification. Preservation of the
mother’s residual urine output, maintenance of dialy-
sis adequacy and nutritional concerns must be
handled promptly. It must be highlighted that late
diagnosis of pregnancy has been shown to increase
maternal and fetal complications [9].
Pregnant ESRD woman have higher maternal and fetal
morbidity and mortalitiy rates as compared to women
with normal renal function [10]. The likelihood of an in-
fant surviving in women who conceive after initiation of
dialysis is 50%. Premature rupture of membrane, polyhy-
dramnios, intrauterine growth retardation, preterm
birth, preeclampsia/eclampsia, placental abruption, an-
aemia, haemorrhage, miscarriage and maternal death are
amongst the obstetrical nightmares that may occur. For
those on haemodialysis, hypertension and anaemia are
frequent maternal clinical concerns whereas intrauterine
death and preterm infants were the most commonly re-
ported fetal complications.
The risks are further magnified and compounded
when the patient falls in the category of advanced age
for pregnancy. Obstetric risks associated with adverse
outcome in pregnancy for women aged 35 years and
above were quantified in a large retrospective data of
385,120 singleton pregnancies analysed in the North
West Thames Region, UK [11]. In this study, pregnant
women aged 35–40 years old were at risk of gestational
diabetes, placenta praevia, breech presentation, operative
vaginal delivery, emergency caesarean section, postpar-
tum haemorrhage, premature delivery, small gestational
age and still birth. Women aged 40 years and above had
higher odds ratio for the same risks. The study con-
firmed that advanced maternal age is an independent
risk factor for adverse outcomes in pregnancy. On a
positive note, older women were significantly more likely
to breast-feed and this may reflect more positive atti-
tudes towards breast-feeding in older women. These
women usually have greater financial security, social sta-
bility and age-related attributes such as emotional
maturity and wisdom. Unfortunately the study did not
analyse the association of chronic kidney disease (CKD)
and its adverse outcomes.
The other complications that occurred may have been
attributed to the PD therapy itself. Although peritonitis
remains a risk, it can still be treated successfully in preg-
nancy [12].
Despite multiple challenges faced by ESRD women on
dialysis, continuous improvement in maternal–fetal care,
dialysis efficiency, frequency and supportive therapy
provided by nephrologist and obstetrician has paved the
way towards achieving previously inaccessible targets.
Both, PD and HD are feasible modes of renal replace-
ment therapy for pregnant CKD patients. While HD
enables precise fluid control, it however may lead to
marked hemodynamic instability and blood pressure
fluctuations that can impair placental blood flow. PD, on
the other hand provides a more gentle and continuous
mode of dialysis, with less fluctuations in maternal intra-
vascular volumes. According to Okundaye et al., the
occurrence of pregnancy is more common in women on
HD rather than those on PD (2.4% versus 1.1%). Once
conceived however [12], pregnant chronic dialysis
women have better hope for a successful pregnancy
while on PD. The reasons include a higher residual renal
function, more stable metabolic milieu and the absence
of intradialytic hypotension that could potentially cause
intrauterine growth retardation and fetal death. Naka-
bayashi conducted a survey in a Japanese dialysis unit
where there were 15 pregnancies conceived on dialysis.
Fetal survival was associated with the initiation of dialy-
sis of less than 6 years of duration, residual urine pro-
duction of equal or more than 50 ml per day, a
gestational age of at least 33 weeks and birth weight of
greater than median of 1782 grams. All patients who
underwent more than 9 years of dialysis did not have a
surviving infant [13].
Since PD delivery is very much dependant on the PD
catheter, uterine enlargement during pregnancy may
alter the catheter position and prescribed therapy effi-
ciency. Respectable residual renal function greatly
lessens the impact of poor solute and water clearance
due to mechanical causes [14]. The continuous removal
of toxic waste and the resulting steady blood toxin levels
help to maintain a stable intrauterine metabolic milieu,
thus reducing the risk of developing polyhydramnios.
Although the pathophysiology of polyhydramnios in
ESRD patients is unknown, it seems that having a higher
urea level before a HD session may induce solute
diuresis by the normal fetal kidneys, thus increasing
amniotic fluid production. An alternative or additional
explanation may be that frequent and relatively rapid re-
moval of solutes during HD in patients with decreased
oncotic pressure may shift free water into the amniotic
cavity [15]. Once polyhydramnios develope, it increases
the risk of premature labor.
It is not an easy feat to get through pregnancy while
on HD, as the patient needs to commit to undergo noc-
turnal dialysis up to 8 h per night or daily 4 h HD
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sessions. This demanding HD schedule is one of the
main reasons for the improvements in outcomes
observed in the past decade. Similarly an obstacle faced
by PD patients will be of the increase in intra-abdominal
volume in the presence of the gravid uterus that may
reduce the available peritoneal cavity for an effective and
adequate peritoneal exchange. This concern can be min-
imized by reducing the peritoneal fluid exchange
volumes and by performing more frequent exchanges.
There is also an uncertainty regarding the target clear-
ance for pregnant PD patients. It has been suggested
that the Kt/V for PD patients should be increased to the
range of 2.2–2.4 for better pregnancy outcomes, but this
remains to be proven. To achieve this Kt/V target,
therapy volume of up to 20 L per day has been recom-
mended [16]. This approach is not practical in our case
as besides doubling up the therapy cost incurred for
dialysate, it will also require a PD continuous cycler
machine. Instead, most nephrologists would choose to
treat the patient clinically, monitoring blood parameters
and adjusting the PD prescription as needed rather than
following the Kt/v number blindly.
Over the last decade, multiple literatures have stressed
the importance of residual urine output with regards to
successful pregnancy outcomes [15, 17]. Thus it makes
sense to encourage ESRD patients to try for pregnancy
early in their course of ESRD if they understand the
risks involved and yet are longing to have offspring.
However the exact amount of residual urine has not
been properly addressed before.
As our knowledge and experience in managing preg-
nant ESRD women has been improving over the last 4
decades, counselling for ESRD women who wish to
conceive, should include the success rate, risks to the
mother and baby, importance of adherence to dialysis
schedule, and long-term results. In fact there is sugges-
tion that the current dissuasive counselling policy will
need to be changed in view of the relatively positive
outcomes that were attained over last decade [6].
Closely coordinated follow up between the attending
nephrologist and obstetrician specialized in high risk
pregnancy is crucial. The absence of other co-morbidi-
ties, well controlled blood pressure, stable biochemical
parameters, especially haemoglobin and respectable re-
sidual renal function strongly contributes to successful
and uneventful pregnancy in advanced maternal age.
Avoidance of vitamin B12, folate and iron deficiency
with vitamin D and calcium administration is safe and
recommended [17].
Conclusion
Our experience with this patient shows that the absence
of significant co-morbidities and good initial residual
renal function promotes an uneventful and successful
pregnancy in women on chronic dialysis despite being in
her early 40s. Adequate collaboration and support
amongst family, doctors, nurses and the patient is of
essence in ensuring that the sweet journey of elderly
pregnancy is fruitful and memorable.
Abbreviation
CAPD: Continuous ambulatory peritoneal dialysis; CKD: Chronic kidney
disease; ESRD: End stage renal disease; HCG: Human chorionic gonadotropin;
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